France Cardiovascular Devices Market

France Cardiovascular Devices Market Insights Forecasts to 2035

• The France Cardiovascular Devices Market Size Was Estimated at USD 2,650.05 Million in 2024
• The France Cardiovascular Devices Market Size is Expected to Grow at a CAGR of Around 6.7% from 2024 to 2035
• The France Cardiovascular Devices Market Size is Expected to Reach USD 5,405.6 Million By 2035

According to a research report published by Decision Advisor & Consulting, the France Cardiovascular Devices Market size is projected to reach USD 5,405.6 million by 2035, growing at a CAGR of 6.7% from 2025 to 2035. The France cardiovascular devices market is driven by the rising prevalence of heart diseases and an aging population, which increases the need for diagnostic, monitoring, and interventional cardiac devices. Strong technological progress, such as minimally invasive stents, transcatheter heart valves, wearable heart monitors, and AI-based diagnostic tools, also boosts market growth by improving accuracy and reducing recovery times. In addition, France well-established healthcare system and government-backed R&D programs and investments in medical innovation further encourage the development and adoption of cardiovascular technologies across hospitals and clinics in the country.

Market Overview

The France cardiovascular devices market refers to the France medical technology industry that includes all devices used to diagnose, monitor, and treat cardiovascular diseases. This market covers a wide range of products such as stents, pacemakers, defibrillators (ICDs), heart valves, catheters, cardiac monitors, imaging systems, and minimally invasive surgical devices. These devices are used in hospitals, clinics, and diagnostic centers to manage conditions like coronary artery disease, arrhythmias, heart failure, and vascular disorders. Market growth is supported by rising cardiovascular disease cases, advancements in medical technology, and strong healthcare and government support in France.

The France cardiovascular devices market will center on the growing need for minimally invasive cardiac procedures, advanced remote monitoring, and improved preventive care, as cardiovascular diseases continue to rise with an aging population. The expansion of telecardiology, AI-enabled diagnostics, wearable heart monitors, and next-generation transcatheter technologies such as TAVR and smart stents. These advances create strong opportunities for innovation in home-based cardiac monitoring, hybrid operating rooms, robotic-assisted interventions, and fully implantable cardiac-support devices.

The France government is actively supporting this growth through major funding programs under the France 2030 Health Innovation Plan, which allocates around USD 8.1 billion to strengthen medical innovation, including  USD 432 million specifically earmarked for advanced medical devices. Additionally, cardiovascular innovation is directly supported through targeted grants of about USD 8.4 million awarded to FineHeart for developing its breakthrough FlowMaker cardiac device. These initiatives, combined with strong reimbursement policies and national screening efforts, position France to advance rapidly in cardiovascular technology and care delivery.

Report Coverage

This research report categorizes the market for the France cardiovascular devices market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France cardiovascular devices market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France cardiovascular devices market.

Driving Factors

The France cardiovascular devices market is driven by a rising prevalence of cardiovascular diseases, an aging population, and a strong government focus on preventive care and innovation. For instance, France is actively investing in research and development to position itself as a leader in health innovation. "France 2030" Plan: This initiative includes a €7.5 billion budget for health innovation, with €400 million specifically dedicated to innovative medical devices. Other key drivers include the increasing demand for advanced technologies like remote and AI-powered monitoring, a preference for minimally invasive procedures, and France's consolidated, tech-friendly healthcare system.

Restraining Factors

Restraining factors for the France cardiovascular devices market include stringent and complex regulatory policies, high equipment and procedural costs, and economic uncertainties such as energy prices and geopolitical tensions affecting healthcare spending. Additional challenges include difficulties with reimbursement, intense competition, a shortage of skilled professionals, and market access hurdles, especially for new entrants. 

Market Segmentation

The France cardiovascular device market share is categorized by product, diagnostic & monitoring device type, surgical device type, and end user.

• The surgical device segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The France cardiovascular devices market is segmented by product into diagnostic device, monitoring device, surgical device, and others. Among these, the surgical devices segment accounted for the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The surgical devices’ segmental growth is due to the increasing volume of cardiovascular surgeries and the growing demand for interventional and implantable cardiac devices such as pacemakers, implantable defibrillators (ICDs), catheters, and coronary stents. This growth is driven by the increasing prevalence of cardiovascular diseases, the aging population, and the strong adoption of minimally invasive surgical procedures in France.

• The ECG segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

The France cardiovascular devices market is segmented by diagnostic & monitoring device type into ECG, implantable cardiac monitors, holter monitors, mobile cardiac telemetry, MRI, and others. Among these, the ECG segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The ECG segmental dominance is due to its user-friendly design, seamless integration with mobile technologies, and ability to facilitate continuous, remote patient monitoring. These features increased patient compliance and engagement, supporting the segment's leading market position. 

• The coronary stents segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.  

The France cardiovascular devices market is segmented by surgical device type into cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), pacemakers, coronary stents, and catheters. Among these. The coronary stents dominated the market in 2024 and are projected to grow at a substantial CAGR during the forecast period. The coronary stents’ segmental dominance is due to the high prevalence of coronary artery disease, increasing number of percutaneous coronary interventions (PCI), growing preference for minimally invasive procedures, and advancements in stent technology, such as drug-eluting and bioresorbable stents, which improve patient outcomes and reduce complications.

• The hospitals & clinics segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

The France cardiovascular devices market is segmented by end user into hospitals & clinics, diagnostic laboratories, ambulatory surgical centers, and others. Among these, the hospitals & clinics segment held the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The hospitals & clinics segmental growth is due to the high volume of patients, advanced infrastructure, and a wide range of procedures performed in these settings. They manage a high volume of complex cardiovascular cases and possess the infrastructure for interventional procedures (like PCI and device implantation). These facilities are primary centers for both diagnosis and complex interventions like surgeries and stenting, where trained professionals and specialized equipment are readily available. 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France cardiovascular devices market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 List of Key Companies

• Abbott
• GE HealthCare
• Edwards Lifesciences Corporation
• L. Gore & Associates, Inc.
• Siemens Healthcare
• GmbH BIOTRONIK SE & Co. KG
• Canon Medical Systems Asia Pte. Ltd.
• Cardinal Health
• Medtronic
• Boston Scientific Corporation
• Johnson & Johnson Services, Inc.
• LivaNova
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In February 2025, Abbott issued a safety notification for certain Assurity and Endurity pacemakers due to potential epoxy mixing issues during manufacturing, which could lead to device malfunction.
• In April 2025, GE HealthCare launched the Revolution Vibe CT system featuring Unlimited One-Beat Cardiac imaging and AI solutions, enhancing cardiac imaging capabilities.

Market Segment

This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Decision Advisor has segmented the France Cardiovascular Devices Market based on the below-mentioned segments:

France Cardiovascular Devices Market, By Product

• Diagnostic Device
• Monitoring Device
• Surgical Device

France Cardiovascular Devices Market, By Diagnostic & Monitoring Device Type

• ECG
• Implantable Cardiac Monitors
• Holter Monitors
• Mobile Cardiac Telemetry
• MRI
• Others

France Cardiovascular Devices Market, By Surgical Device Type

• Cardiac Resynchronization Therapy (CRT)
• Implantable Cardioverter Defibrillators (ICDs)
• Pacemakers
• Coronary Stents
• Catheters
• Others

France Cardiovascular Devices Market, By End User

• Hospitals & Clinics
• Diagnostic Laboratories
• Ambulatory Surgical Centers
• Others

Frequently Asked Questions (FAQ)

1. What is the CAGR of the France cardiovascular devices market?

The France cardiovascular devices market size is expected to grow at a CAGR of around 6.7% from 2024 to 2035.

2. What is the France cardiovascular devices market size in 2024?

The France cardiovascular devices market size was estimated at USD 2,650.05 million in 2024.

3. What is the projected market size of the France cardiovascular devices market by 2035?

The France cardiovascular devices market size is expected to reach USD 5,405.6 million by 2035.

4. What are the key growth drivers of the France cardiovascular devices market?

Rising prevalence of cardiovascular diseases, an aging population, and a strong government focus on preventive care and innovation. Increasing demand for advanced technologies.

5. Which end user segment held the largest share in 2024?

The hospitals & clinics segment held the largest market share in 2024.

6. Which product segment accounted for the largest market share in 2024?

The surgical device segment accounted for the largest market share in 2024.